Internship

Business Development Summer Intern

Posted on 3/14/2023

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

Combining AI and biotechnology for drug discovery


Burlingame, CA, USA + 2 more

Required Skills
Communications
Requirements
  • Currently enrolled in EITHER a life sciences PhD program (e.g., bioengineering, chemistry) OR a top-tier MBA program with prior experiences in the life sciences industry
  • Familiarity with life sciences and drug development via prior roles, internships, consulting, academic research, or academic groups (e.g., life sciences consulting clubs)
  • Prior experience supporting corporate strategy and/or business development work, ideally in life sciences, including primary/secondary research and quantitative/qualitative analyses
  • Knowledge of oncology, computational small molecule drug discovery, and/or AI drug discovery platform landscape would be preferred, but not required
  • Excellent communication, listening and strong presentation skills
  • An undergraduate degree in life sciences or related field preferred
  • If remote, ability for occasional travel to San Francisco Bay Area
Responsibilities
  • Research pharma pipelines, commercial portfolios, and key stakeholders to help identify and prioritize potential partnerships based on Genesis' strategic objectives and AI platform
  • Analyze comparable deals and collaborate with a diverse set of Genesis Therapeutics stakeholders to set objectives and draft potential terms for platform and/or asset partnerships
  • Support preparation of materials for ongoing discussions with actual/potential pharma partners, and assist other activities across end-to-end business development processes
  • Contribute to other corporate strategy initiatives (e.g., market sizing, competitive research)

Genesis Therapeutics is on a mission to transform every stage of drug discovery to solve critical patient needs. The company is unlocking novel protein targets, exploring untapped chemical space, and accelerating the development of critical new medicines with the industry's most advanced molecular AI platform.

Company Stage

Series B

Total Funding

$256.1M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

21%

1 year growth

21%

2 year growth

21%

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

INACTIVE